The TRPM4 channel inhibitor 9-phenanthrol.

Area of Science:

• Pharmacology
• Ion Channel Physiology
• Cardiovascular Research

Background:

• 9-phenanthrol is a specific inhibitor of the Transient Receptor Potential Melastatin 4 (TRPM4) channel.
• TRPM4 is a Ca(2+)-activated non-selective cation channel with an incompletely understood mechanism of action.
• 9-phenanthrol's specificity for TRPM4 has been confirmed across various ion channels.

Purpose of the Study:

• To review the biophysical effects of 9-phenanthrol on TRPM4 channels.
• To explore the physiological processes modulated by 9-phenanthrol through TRPM4 inhibition.
• To discuss potential clinical applications and appropriate use in physiological studies.

Main Methods:

• Inhibition of TRPM4 channel activity by 9-phenanthrol.
• Assessment of 9-phenanthrol's effects on smooth muscle contraction (bladder, cerebral arteries).
• Evaluation of 9-phenanthrol's impact on neuronal and cardiac spontaneous activity.
• Investigation of 9-phenanthrol's role in lipopolysaccharide-induced cell death.

Main Results:

• 9-phenanthrol specifically inhibits TRPM4 channels.
• Modulation of smooth muscle contraction, neuronal activity, and cardiac function by 9-phenanthrol.
• Demonstrated cardioprotective effects against ischemia-reperfusion injuries.
• Reduced severity of ischemic stroke injuries.
• Reduction in lipopolysaccharide-induced cell death.

Conclusions:

• 9-phenanthrol is a specific TRPM4 inhibitor with broad physiological modulatory effects.
• 9-phenanthrol exhibits significant therapeutic potential in cardiovascular conditions like ischemia-reperfusion and stroke.
• Further research into the clinical applications of 9-phenanthrol is warranted.